Supplemental tables with minimum to maximum values for all variables as well as parameter estimates with 95% confidence intervals for bivariate and multivariate linear regression models are included in the supplemental information. Table A. Baseline patient characteristics by C-reactive protein levels. Data reported as the range of minimum-maximum values or number (percent). Parameter estimates with 95% confidence intervals are reported for bivariate linear regression models and multivariate linear regression models adjusted for age, body mass index (BMI) and statin use. Abbreviations: ACE: Angiotensin converting enzyme, ARB: Angiotensin receptor blocker, CITP: C-telopeptide for type I collagen, COPD: Chronic obstructive pulmonary disease, ...
Supplementary Table 1. Comparison of the basic clinical data in each group of participants categor...
Cohort characteristics of patients with severe CAD planned to undergo CABG surgery and age matched h...
All-cause mortality risk for subjects overall and those who survived at least 1, 2, and 3 years afte...
Association Between Biomarkers and COPD Outcomes. Table S2. Statistical Models. Table S3. Demographi...
Table S1. Serum biomarkers in 2005, comparing subjects participating respectively alive but not part...
Supplemental Material. Figure S1. Participants included in the Biocohort in the IMMEDIATE Trial. Fig...
Additional file 1: Table S1. Comparison of raw and log-transformed sST2, hs-cTnI, and NT-proBNP seru...
Additional file 1: Table S1. Number of participants and participations in the follow-up visits. Tabl...
Tables S1a and S1b: Baseline characteristics in relation to quartiles of FVC%predicted, males and fe...
Is presenting results analyzed using a nonimputed data set. *Adjusted for demographics, health behav...
<p>Supplemental_Table for A Randomized Trial Comparing Cardiac Rehabilitation to Standard of Care fo...
Table S1. The relationship between hs-CRP and biomarkers stratified by gender in healthy population....
Table S1. Demographics of patients without COPD. Table S2. Demographics of patients with COPD. Table...
State occupation probabilities and transition hazards: A supplementary description of statistical me...
Table S1. Number of participants with missing data for covariates. Table S2. Cut-off points for age-...
Supplementary Table 1. Comparison of the basic clinical data in each group of participants categor...
Cohort characteristics of patients with severe CAD planned to undergo CABG surgery and age matched h...
All-cause mortality risk for subjects overall and those who survived at least 1, 2, and 3 years afte...
Association Between Biomarkers and COPD Outcomes. Table S2. Statistical Models. Table S3. Demographi...
Table S1. Serum biomarkers in 2005, comparing subjects participating respectively alive but not part...
Supplemental Material. Figure S1. Participants included in the Biocohort in the IMMEDIATE Trial. Fig...
Additional file 1: Table S1. Comparison of raw and log-transformed sST2, hs-cTnI, and NT-proBNP seru...
Additional file 1: Table S1. Number of participants and participations in the follow-up visits. Tabl...
Tables S1a and S1b: Baseline characteristics in relation to quartiles of FVC%predicted, males and fe...
Is presenting results analyzed using a nonimputed data set. *Adjusted for demographics, health behav...
<p>Supplemental_Table for A Randomized Trial Comparing Cardiac Rehabilitation to Standard of Care fo...
Table S1. The relationship between hs-CRP and biomarkers stratified by gender in healthy population....
Table S1. Demographics of patients without COPD. Table S2. Demographics of patients with COPD. Table...
State occupation probabilities and transition hazards: A supplementary description of statistical me...
Table S1. Number of participants with missing data for covariates. Table S2. Cut-off points for age-...
Supplementary Table 1. Comparison of the basic clinical data in each group of participants categor...
Cohort characteristics of patients with severe CAD planned to undergo CABG surgery and age matched h...
All-cause mortality risk for subjects overall and those who survived at least 1, 2, and 3 years afte...